NDC00014-1011-52: SPIRONOLACTONE AND HYDROCHLOROTH.
SPIRONOLACTONE AND HYDROCHLOROTH. Key specifications include primary_container_type: BOTTLE, primary_container_content_quantity: 1000.000 TABLETS, active_medicament_medicinal_strength: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-222-6567, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE |
| primary_container_content_quantity | 1000.000 TABLETS |
| active_medicament_medicinal_strength | 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT |
| NSN | 6505-01-222-6567 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 TABLETS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.